"The Cancer Center at Tufts Medical Center offers some of the most advanced cancer treatments in New England, going above and beyond to make sure patients are as comfortable as possible. Provided by The Cam Neely Foundation for Cancer Care, the Neely House is a bed-and-breakfast located within the Medical Center that acts as a home away from home for patients and families. Tufts MC also offers Boston’s only Adolescent and Young Adult Cancer Program for patients aged 18-39, and Northern New England’s only Gamma Knife Center, which specializes in treating brain tumors non-surgically."

During the past decade, Tufts-NEMC Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 18 clinical trials were completed, i.e. on average, 900% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tufts-NEMC Cancer Center" #1 sponsor was "Eastern Cooperative Oncology Group" with 9 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Gynecologic Oncology Group" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "ETOP IBCSG Partners Foundation" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tufts-NEMC Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Tufts-NEMC Cancer Center" are "Breast Cancer" (7 trials), "Leukemia" (5 trials), "Lymphoma" (4 trials), "Lung Cancer" (3 trials) and "Melanoma (Skin)" (2 trials). Many other conditions were trialed in "Tufts-NEMC Cancer Center" in a lesser frequency.

Most popular intervention types in "Tufts-NEMC Cancer Center" are "Drug" (27 trials), "Biological" (12 trials), "Procedure" (12 trials), "Radiation" (12 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "radiation therapy" (6 trials), "cisplatin" (4 trials), "carboplatin" (3 trials) and "paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Tufts-NEMC Cancer Center" are 23 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Tufts-NEMC Cancer Center". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Tufts-NEMC Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Tufts-NEMC Cancer Center, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".